Investigators discuss the use of targeted therapies to treat metastatic colorectal cancer.
Jeremy C. Jones, MD
Advertisement
Articles by Jeremy C. Jones, MD
Patients with colorectal cancer could benefit from the COLMATE platform as it allows for opportunities in clinical trial enrollment.
Advertisement
Latest Updated Articles
Addressing Resistance to Targeted Therapies in Metastatic Colorectal CancerPublished: October 21st 2021 | Updated:
The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE PlatformPublished: September 15th 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Addressing Systemic Barriers to Dermatologic Consultation in Oncology Care
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
